{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:20:35Z","timestamp":1785450035654,"version":"3.56.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Post-capillary pulmonary hypertension (pcPH) is a frequent complication of heart failure (HF), associated with poor outcomes. While right heart catheterization (RHC) is the diagnostic gold standard, echocardiographic indices such as left atrial volume index (LAVI) and the TAPSE\/PASP ratio may offer non-invasive prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the prognostic utility of LAVI and TAPSE\/PASP compared with invasive haemodynamic parameters in patients with HF and pcPH undergoing RHC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The PH\u2013HF study is a prospective multicentre cohort of adults with chronic HF and confirmed pcPH (mPAP &amp;gt; 20\u2005mmHg and pulmonary arterial wedge pressure &amp;gt; 15\u2005mmHg) enrolled across 13 French centres (2012\u20132018). Patients with precapillary PH or severe pulmonary\/renal comorbidities were excluded. The primary outcome was a 3-year composite of all-cause mortality, urgent heart transplantation or LVAD, or unplanned HF hospitalization. Cox regression was used for survival analyses. Overall, 55% of patients met the composite echocardiographic risk criterion (LAVI &amp;gt; 35\u2005mL\/m\u00b2 or TAPSE\/PASP &amp;lt; 0.40), which was associated with increased risk of adverse events (HR 1.97, 95% CI 1.41\u20132.75; P &amp;lt; 0.0001). Results were consistent across HFrEF and HFpEF phenotypes. In a multivariable model including the MAGGIC score, both the echocardiographic criterion and the clinical score remained independently associated with outcomes, supporting their complementary value in risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LAVI and TAPSE\/PASP are strong, non-invasive predictors of adverse outcomes in HF with pcPH and may enhance prognostic assessment beyond invasive haemodynamics and clinical scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeag034","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:41:20Z","timestamp":1769604080000},"page":"820-830","source":"Crossref","is-referenced-by-count":1,"title":["Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE\/PASP"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-3110","authenticated-orcid":false,"given":"Emmanuelle","family":"Berthelot","sequence":"first","affiliation":[{"name":"INSERM, UMR__S1358, Hypertension Pulmonaire: Physiopathologie et Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, FHU Andr\u00e9 Cournand, Universit\u00e9 Paris-Saclay , Le Plessis- Robinson ,","place":["France"]},{"name":"Service de Cardiologie, H\u00f4pital Bic\u00eatre, AP-HP, Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bauer","sequence":"additional","affiliation":[{"name":"INSERM, UMR__S1358, Hypertension Pulmonaire: Physiopathologie et Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, FHU Andr\u00e9 Cournand, Universit\u00e9 Paris-Saclay , Le Plessis- Robinson ,","place":["France"]},{"name":"Service de Cardiologie, H\u00f4pital Bic\u00eatre, AP-HP, Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Fauvel","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Cardiologie, H\u00f4pital Charles Nicolle, CHU de Rouen, Rouen ,","place":["France"]},{"name":"Department of cardiologue, Centre de Comp\u00e9tence en Hypertension Pulmonaire 27\/76, CHU de Rouen , Rouen ,","place":["France"]},{"name":"INSERM U1096, Universit\u00e9 de Rouen Normandie , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Paclot","sequence":"additional","affiliation":[{"name":"INSERM, UMR__S1358, Hypertension Pulmonaire: Physiopathologie et Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, FHU Andr\u00e9 Cournand, Universit\u00e9 Paris-Saclay , Le Plessis- Robinson ,","place":["France"]},{"name":"Service de Cardiologie, H\u00f4pital Bic\u00eatre, AP-HP, Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Eicher","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, CHU de Dijon-H\u00f4pital Fran\u00e7ois Mitterrand , Dijon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6211-0147","authenticated-orcid":false,"given":"Pascal","family":"de Groote","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, CHU de Lille , Lille ,","place":["France"]},{"name":"INSERM U1167, Institut Pasteur de Lille , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-No\u00ebl","family":"Trochu","sequence":"additional","affiliation":[{"name":"Department of cardiologie, L'institut du thorax, CHU de Nantes, Universit\u00e9 de Nantes, CNRS, INSERM , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Picard","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, H\u00f4pital Cardiologique Haut-L\u00e9v\u00eaque, CHU de Bordeaux, Universit\u00e9 de Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Renard","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, H\u00f4pital de la Timone, AP-HM , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bouvaist","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, H\u00f4pital Michallon, CHU de Grenoble , Grenoble ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Logeart","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, H\u00f4pital Bichat, AP-HP, Universit\u00e9 de Paris , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-9687","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Cardiologie, CHU de Montpellier, Universit\u00e9 de Montpellier, INSERM, CNRS , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[{"name":"INSERM, UMR__S1358, Hypertension Pulmonaire: Physiopathologie et Innovation Th\u00e9rapeutique (HPPIT), AP-HP, H\u00f4pital Bic\u00eatre, H\u00f4pital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, FHU Andr\u00e9 Cournand, Universit\u00e9 Paris-Saclay , Le Plessis- Robinson ,","place":["France"]},{"name":"Service de Pneumologie et Soins Intensifs Respiratoires, H\u00f4pital Bic\u00eatre, AP-HP , Le Kremlin- Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[{"name":"R\u00e9seau Cardiogen, D\u00e9partement de Cardiologie, Centre Fran\u00e7ais de R\u00e9f\u00e9rence de L\u2019Amylose Cardiaque (CRAC), CHU Henri-Mondor , Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-1241","authenticated-orcid":false,"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, CHU de Lille , Lille ,","place":["France"]},{"name":"INSERM U1167, Institut Pasteur de Lille , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026032621015637500_jeag034-B1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension\u2020","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"2026032621015637500_jeag034-B2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026032621015637500_jeag034-B3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026032621015637500_jeag034-B4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study","volume":"8","author":"Maron","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026032621015637500_jeag034-B5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary hypertension in HFpEF and HFrEF","volume":"76","author":"Guazzi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026032621015637500_jeag034-B6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/688516","article-title":"Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension","volume":"6","author":"Assad","year":"2016","journal-title":"Pulm Circ"},{"key":"2026032621015637500_jeag034-B7","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1093\/eurheartj\/ehae467","article-title":"Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study","volume":"45","author":"Fauvel","year":"2024","journal-title":"Eur Heart J"},{"key":"2026032621015637500_jeag034-B8","doi-asserted-by":"crossref","first-page":"e004436","DOI":"10.1161\/CIRCHEARTFAILURE.117.004436","article-title":"Pulmonary effective arterial elastance as a measure of right ventricular afterload and its prognostic value in pulmonary hypertension due to left heart disease","volume":"11","author":"Tampakakis","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026032621015637500_jeag034-B9","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"2026032621015637500_jeag034-B10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardfail.2011.12.003","article-title":"Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure","volume":"18","author":"Damy","year":"2012","journal-title":"J Card Fail"},{"key":"2026032621015637500_jeag034-B11","doi-asserted-by":"crossref","first-page":"e009047","DOI":"10.1161\/CIRCIMAGING.119.009047","article-title":"Validation of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio for the assessment of right ventricular- arterial coupling in severe pulmonary hypertension","volume":"12","author":"Tello","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026032621015637500_jeag034-B12","doi-asserted-by":"crossref","first-page":"e019545","DOI":"10.1161\/JAHA.120.019545","article-title":"Prognostic value of minimal left atrial volume in heart failure with preserved ejection fraction","volume":"10","author":"Shin","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026032621015637500_jeag034-B13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/ehjci\/jeae059","article-title":"In-hospital prognostic value of TAPSE\/sPAP in patients hospitalized for acute heart failure","volume":"25","author":"Fauvel","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026032621015637500_jeag034-B14","first-page":"995","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"15","author":"Pocock","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026032621015637500_jeag034-B15","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2016.09.942","article-title":"Clinical and biological insights into combined post- and Pre-capillary pulmonary hypertension","volume":"68","author":"Assad","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026032621015637500_jeag034-B16","doi-asserted-by":"crossref","first-page":"935103","DOI":"10.3389\/fcvm.2022.935103","article-title":"Prognostic value of left atrial strain in heart failure: a systematic review and meta-analysis","volume":"9","author":"Jia","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026032621015637500_jeag034-B17","doi-asserted-by":"crossref","first-page":"e007696","DOI":"10.1161\/CIRCIMAGING.118.007696","article-title":"Left atrial reservoir function and outcome in heart failure with reduced ejection fraction: the importance of atrial strain by speckle tracking echocardiography","volume":"11","author":"Carluccio","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026032621015637500_jeag034-B18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ehjci\/jeaa285","article-title":"Pressure\u2013volume loop validation of TAPSE\/PASP for right ventricular arterial coupling in heart failure with pulmonary hypertension","volume":"22","author":"Schmeisser","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026032621015637500_jeag034-B19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.amjcard.2019.05.024","article-title":"Usefulness of right ventricular to pulmonary circulation coupling as an indicator of risk for recurrent admissions in heart failure with preserved ejection fraction","volume":"124","author":"Santas","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026032621015637500_jeag034-B20","doi-asserted-by":"crossref","first-page":"00941","DOI":"10.1183\/23120541.00941-2020","article-title":"The isobaric pulmonary arterial compliance in pulmonary hypertension","volume":"7","author":"Chemla","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026032621015637500_jeag034-B21","doi-asserted-by":"crossref","first-page":"e002729","DOI":"10.1161\/CIRCHEARTFAILURE.115.002729","article-title":"Impaired right ventricular\u2013pulmonary arterial coupling and effect of sildenafil in heart failure with preserved ejection fraction: an ancillary analysis from the phosphodiesterase-5 inhibition to improve clinical Status and exercise capacity in diastolic heart failure (RELAX) trial","volume":"9","author":"Hussain","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026032621015637500_jeag034-B22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jcmg.2016.12.024","article-title":"RV Contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction","volume":"10","author":"Guazzi","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026032621015637500_jeag034-B23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ehf2.12316","article-title":"Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues","volume":"5","author":"Berthelot","year":"2018","journal-title":"ESC Heart Fail"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag034\/66635801\/jeag034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/4\/820\/66635801\/jeag034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/4\/820\/66635801\/jeag034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T01:02:07Z","timestamp":1774573327000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/4\/820\/8444832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag034","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,30]]}}}